• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Factors influencing the survival of patients with transitional cell tumours of the urinary bladder.

作者信息

Pryor J P

出版信息

Br J Urol. 1973 Dec;45(6):586-92. doi: 10.1111/j.1464-410x.1973.tb12227.x.

DOI:10.1111/j.1464-410x.1973.tb12227.x
PMID:4775737
Abstract
摘要

相似文献

1
Factors influencing the survival of patients with transitional cell tumours of the urinary bladder.
Br J Urol. 1973 Dec;45(6):586-92. doi: 10.1111/j.1464-410x.1973.tb12227.x.
2
Cystectomy after radiotherapeutic ablation of invasive transitional cell cancer.
J Urol. 1977 Aug;118(2):260-1. doi: 10.1016/s0022-5347(17)57966-5.
3
Invasive transitional cell carcinoma of the bladder: is there a place for preoperative radiotherapy?膀胱浸润性移行细胞癌：术前放疗有必要吗？
Urol Clin North Am. 1980 Oct;7(3):551-7.
4
Bladder carcinoma treated by irradiation and surgery: interval report.
Trans Am Assoc Genitourin Surg. 1972;64:74-8.
5
Radiotherapy and cystectomy for T3 bladder carcinoma.T3期膀胱癌的放射治疗与膀胱切除术
Br J Urol. 1981 Dec;53(6):598-601. doi: 10.1111/j.1464-410x.1981.tb03269.x.
6
Radiation therapy and cystectomy.放射治疗和膀胱切除术。
Urology. 1984 Apr;23(4 Suppl):104-9. doi: 10.1016/s0090-4295(84)80079-5.
7
Superficial bladder tumor. Aspects of clinical progression.
Urology. 1974 Oct;4(4):414-20. doi: 10.1016/0090-4295(74)90010-7.
8
[Preoperative radiotherapy in bladder carcinoma].[膀胱癌的术前放疗]
Strahlenther Onkol. 1998 Mar;174(3):167. doi: 10.1007/BF03038500.
9
[Treatment of transitional cell carcinoma of the urinary bladder].[膀胱移行细胞癌的治疗]
Nihon Hinyokika Gakkai Zasshi. 1988 Mar;79(3):507-12. doi: 10.5980/jpnjurol1928.79.3_507.
10
[Clinical study on transitional cell carcinoma of the bladder].[膀胱移行细胞癌的临床研究]
Nihon Hinyokika Gakkai Zasshi. 1984 Feb;75(2):222-8. doi: 10.5980/jpnjurol1928.75.2_222.

引用本文的文献

1
D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance.D 型细胞周期蛋白在表浅性和肌层浸润性膀胱癌中的表达：与临床病理数据的相关性及其预后意义。
J Cancer Res Clin Oncol. 2010 Oct;136(10):1563-71. doi: 10.1007/s00432-010-0814-y. Epub 2010 Feb 20.
2
Clinical significance of nuclear factor (NF)-kappaB levels in urothelial carcinoma of the urinary bladder.核因子（NF）-κB水平在膀胱尿路上皮癌中的临床意义
Virchows Arch. 2008 Mar;452(3):295-304. doi: 10.1007/s00428-007-0560-y.
3
Epidermal growth factor receptor and bladder cancer.
表皮生长因子受体与膀胱癌
Postgrad Med J. 2002 Oct;78(924):584-9. doi: 10.1136/pmj.78.924.584.
4
Reduced expression of TGF beta is associated with advanced disease in transitional cell carcinoma.转化生长因子β（TGF-β）表达降低与移行细胞癌的疾病进展相关。
Br J Cancer. 1993 Mar;67(3):578-84. doi: 10.1038/bjc.1993.106.
5
The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.肿瘤扩散、分级及生长模式作为膀胱癌形态学预测参数的价值。对1987年TNM分类的批判性修订。
J Cancer Res Clin Oncol. 1993;119(10):578-93. doi: 10.1007/BF01372721.
6
Bladder cancer.膀胱癌
Br Med J (Clin Res Ed). 1981 Jun 27;282(6282):2136-7. doi: 10.1136/bmj.282.6282.2136-c.
7
Prognostic factors in a T3 bladder cancer trial. Co-operative Urological Cancer Group.一项T3期膀胱癌试验中的预后因素。泌尿生殖系统癌症合作组。
Br J Cancer. 1989 Mar;59(3):441-4. doi: 10.1038/bjc.1989.90.
8
ACP Broadsheet 130: November 1991. Gross examination of bladder specimens.《内科学会简报》第130期：1991年11月。膀胱标本的大体检查。
J Clin Pathol. 1991 Nov;44(11):890-5. doi: 10.1136/jcp.44.11.890.
9
Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.c-erbB-2在膀胱移行细胞癌中的扩增与过表达。
Br J Cancer. 1991 Apr;63(4):601-8. doi: 10.1038/bjc.1991.139.
10
Chemotherapy in the management of invasive bladder cancer. A review.
Cancer Chemother Pharmacol. 1979;3(2):87-96. doi: 10.1007/BF00254978.